{"data":{"id":"us/21-cfr-314.630","jurisdiction":"us","citation":"21 CFR 314.630","heading":"Postmarketing safety reporting.","body":"Drug products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting requirements applicable to all approved drug products, as provided in §§ 314.80 and 314.81.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG","Subpart I—Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"8b0dd15497a0ed2496cbcec655507ce3509aea4c62be692c9664764173c639d4","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-314.620","next":"us/21-cfr-314.640"},"notice":"GroundRules: Original legal text. Not legal advice."}